APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rofecoxib

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Rofecoxib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025187 pages

Choose your research edition.

Industry ResearchRofecoxib Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Rofecoxib Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Rofecoxib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rofecoxib Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Rofecoxib Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Rofecoxib market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Rofecoxib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Rofecoxib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rofecoxib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Rofecoxib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Rofecoxib include Wuhan Xinxin Jiali Biotechnology Co. LTD, Merck, Pfizer, Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD, Chengdu Meinkai Chemical Co. LTD and Tremeau, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Rofecoxib market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Rofecoxib and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Rofecoxib sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Rofecoxib market size, projected growth trends, production technologies, key applications, and end-use industries.

Rofecoxib Segment by Company

Wuhan Xinxin Jiali Biotechnology Co. LTD

Merck

Pfizer

Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD

Chengdu Meinkai Chemical Co. LTD

Tremeau

Rofecoxib Segment by Type

Oral Suspension.

Tablet-Form

Rofecoxib Segment by Application

Juvenile Rheumatoid Arthritis

Dysmenorrhea

Migraine

Rheumatoid Arthritis

Acute Pain Conditions

Osteoarthritis

Rofecoxib Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rofecoxib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rofecoxib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rofecoxib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Rofecoxib market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Rofecoxib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Rofecoxib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Rofecoxib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Rofecoxib Industry Trends Table 2. Rofecoxib Industry Drivers Table 3. Rofecoxib Industry Opportunities and Challenges Table 4. Rofecoxib Industry Restraints Table 5. Global Rofecoxib Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Rofecoxib Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Rofecoxib Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Rofecoxib Sales Market Share by Manufacturers Table 9. Global Rofecoxib Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Rofecoxib Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Rofecoxib Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Rofecoxib Manufacturers, Product Type & Application Table 13. Global Rofecoxib Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Rofecoxib by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Oral Suspension. Table 17. Major Manufacturers of Tablet-Form Table 18. Global Rofecoxib Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Rofecoxib Sales by Type (2021-2026) & (k units) Table 20. Global Rofecoxib Sales by Type (2027-2032) & (k units) Table 21. Global Rofecoxib Sales Market Share by Type (2021-2026) Table 22. Global Rofecoxib Sales Market Share by Type (2027-2032) Table 23. Global Rofecoxib Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Rofecoxib Revenue by Type (2021-2026) & (k units) Table 25. Global Rofecoxib Revenue by Type (2027-2032) & (k units) Table 26. Global Rofecoxib Revenue Market Share by Type (2021-2026) Table 27. Global Rofecoxib Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Juvenile Rheumatoid Arthritis Table 29. Major Manufacturers of Dysmenorrhea Table 30. Major Manufacturers of Migraine Table 31. Major Manufacturers of Rheumatoid Arthritis Table 32. Major Manufacturers of Acute Pain Conditions Table 33. Major Manufacturers of Osteoarthritis Table 34. Global Rofecoxib Sales by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Rofecoxib Sales by Application (2021-2026) & (k units) Table 36. Global Rofecoxib Sales by Application (2027-2032) & (k units) Table 37. Global Rofecoxib Sales Market Share by Application (2021-2026) Table 38. Global Rofecoxib Sales Market Share by Application (2027-2032) Table 39. Global Rofecoxib Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 40. Global Rofecoxib Revenue by Application (2021-2026) & (k units) Table 41. Global Rofecoxib Revenue by Application (2027-2032) & (k units) Table 42. Global Rofecoxib Revenue Market Share by Application (2021-2026) Table 43. Global Rofecoxib Revenue Market Share by Application (2027-2032) Table 44. Global Rofecoxib Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Rofecoxib Sales by Region (2021-2026) & (k units) Table 46. Global Rofecoxib Sales Market Share by Region (2021-2026) Table 47. Global Rofecoxib Sales Forecasted by Region (2027-2032) & (k units) Table 48. Global Rofecoxib Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Rofecoxib Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. North America Rofecoxib Sales by Country (2021-2026) & (k units) Table 51. North America Rofecoxib Sales by Country (2027-2032) & (k units) Table 52. Europe Rofecoxib Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Europe Rofecoxib Sales by Country (2021-2026) & (k units) Table 54. Europe Rofecoxib Sales by Country (2027-2032) & (k units) Table 55. Asia Pacific Rofecoxib Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Asia Pacific Rofecoxib Sales by Country (2021-2026) & (k units) Table 57. Asia Pacific Rofecoxib Sales by Country (2027-2032) & (k units) Table 58. South America, Middle East and Africa Rofecoxib Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. South America, Middle East and Africa Rofecoxib Sales by Country (2021-2026) & (k units) Table 60. South America, Middle East and Africa Rofecoxib Sales by Country (2027-2032) & (k units) Table 61. Global Rofecoxib Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Rofecoxib Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Rofecoxib Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Rofecoxib Revenue Market Share by Region (2021-2026) Table 65. Global Rofecoxib Revenue Market Share by Region (2027-2032) Table 66. Wuhan Xinxin Jiali Biotechnology Co. LTD Company Information Table 67. Wuhan Xinxin Jiali Biotechnology Co. LTD Business Overview Table 68. Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product Portfolio Table 70. Wuhan Xinxin Jiali Biotechnology Co. LTD Recent Development Table 71. Merck Company Information Table 72. Merck Business Overview Table 73. Merck Rofecoxib Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Merck Rofecoxib Product Portfolio Table 75. Merck Recent Development Table 76. Pfizer Company Information Table 77. Pfizer Business Overview Table 78. Pfizer Rofecoxib Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Pfizer Rofecoxib Product Portfolio Table 80. Pfizer Recent Development Table 81. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Company Information Table 82. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Business Overview Table 83. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product Portfolio Table 85. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Development Table 86. Chengdu Meinkai Chemical Co. LTD Company Information Table 87. Chengdu Meinkai Chemical Co. LTD Business Overview Table 88. Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Chengdu Meinkai Chemical Co. LTD Rofecoxib Product Portfolio Table 90. Chengdu Meinkai Chemical Co. LTD Recent Development Table 91. Tremeau Company Information Table 92. Tremeau Business Overview Table 93. Tremeau Rofecoxib Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Tremeau Rofecoxib Product Portfolio Table 95. Tremeau Recent Development Table 96. Key Raw Materials Table 97. Raw Materials Key Suppliers Table 98. Rofecoxib Distributors List Table 99. Rofecoxib Customers List Table 100. Research Programs/Design for This Report Table 101. Authors List of This Report Table 102. Secondary Sources Table 103. Primary Sources List of Figures Figure 1. Rofecoxib Product Image Figure 2. Global Rofecoxib Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rofecoxib Market Size (2021-2032) & (US$ Million) Figure 4. Global Rofecoxib Sales (2021-2032) & (k units) Figure 5. Global Rofecoxib Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Rofecoxib Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Oral Suspension. Image Figure 9. Tablet-Form Image Figure 10. Global Rofecoxib Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Rofecoxib Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Rofecoxib Sales Market Share by Type (2021-2032) Figure 13. Global Rofecoxib Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Rofecoxib Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Rofecoxib Revenue Market Share by Type (2021-2032) Figure 16. Juvenile Rheumatoid Arthritis Image Figure 17. Dysmenorrhea Image Figure 18. Migraine Image Figure 19. Rheumatoid Arthritis Image Figure 20. Acute Pain Conditions Image Figure 21. Osteoarthritis Image Figure 22. Global Rofecoxib Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Rofecoxib Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Rofecoxib Sales Market Share by Application (2021-2032) Figure 25. Global Rofecoxib Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Rofecoxib Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Rofecoxib Revenue Market Share by Application (2021-2032) Figure 28. North America Rofecoxib Sales and Growth Rate (2021-2032) & (k units) Figure 29. North America Rofecoxib Sales Market Share by Country (2021-2032) Figure 30. U.S. Rofecoxib Sales and Growth Rate (2021-2032) & (k units) Figure 31. Canada Rofecoxib Sales and Growth Rate (2021-2032) & (k units) Figure 32. Mexico Rofecoxib Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Rofecoxib Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Rofecoxib Sales Market Share by Country (2021-2032) Figure 35. Germany Rofecoxib Sales and Growth Rate (2021-2032) & (k units) Figure 36. France Rofecoxib Sales and Growth Rate (2021-2032) & (k units) Figure 37. U.K. Rofecoxib Sales and Growth Rate (2021-2032) & (k units) Figure 38. Italy Rofecoxib Sales and Growth Rate (2021-2032) & (k units) Figure 39. Netherlands Rofecoxib Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Rofecoxib Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Rofecoxib Sales Market Share by Country (2021-2032) Figure 42. China Rofecoxib Sales and Growth Rate (2021-2032) & (k units) Figure 43. Japan Rofecoxib Sales and Growth Rate (2021-2032) & (k units) Figure 44. South Korea Rofecoxib Sales and Growth Rate (2021-2032) & (k units) Figure 45. Southeast Asia Rofecoxib Sales and Growth Rate (2021-2032) & (k units) Figure 46. India Rofecoxib Sales and Growth Rate (2021-2032) & (k units) Figure 47. Australia Rofecoxib Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Rofecoxib Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Rofecoxib Sales Market Share by Country (2021-2032) Figure 50. Brazil Rofecoxib Sales and Growth Rate (2021-2032) & (k units) Figure 51. South Africa Rofecoxib Sales and Growth Rate (2021-2032) & (k units) Figure 52. Saudi Arabia Rofecoxib Sales and Growth Rate (2021-2032) & (k units) Figure 53. Turkey Rofecoxib Sales and Growth Rate (2021-2032) & (k units) Figure 54. Argentina Rofecoxib Sales and Growth Rate (2021-2032) & (k units) Figure 55. UAE Rofecoxib Sales and Growth Rate (2021-2032) & (k units) Figure 56. Egypt Rofecoxib Sales and Growth Rate (2021-2032) & (k units) Figure 57. Chile Rofecoxib Sales and Growth Rate (2021-2032) & (k units) Figure 58. Global Rofecoxib Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Rofecoxib Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Rofecoxib Revenue (2021-2032) & (US$ Million) Figure 61. North America Rofecoxib Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Rofecoxib Revenue (2021-2032) & (US$ Million) Figure 63. Europe Rofecoxib Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Rofecoxib Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Rofecoxib Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Rofecoxib Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Rofecoxib Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Rofecoxib Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Rofecoxib Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Suspension.
  • Tablet-Form
Applications
  • Juvenile Rheumatoid Arthritis
  • Dysmenorrhea
  • Migraine
  • Rheumatoid Arthritis
  • Acute Pain Conditions
  • Osteoarthritis
Companies covered
  • Wuhan Xinxin Jiali Biotechnology Co. LTD
  • Merck
  • Pfizer
  • Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
  • Chengdu Meinkai Chemical Co. LTD
  • Tremeau

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Rofecoxib Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Rofecoxib Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Rofecoxib Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Rofecoxib Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Rofecoxib Market Dynamics
  1. 2.1 Rofecoxib Industry Trends
  2. 2.2 Rofecoxib Industry Drivers
  3. 2.3 Rofecoxib Industry Opportunities and Challenges
  4. 2.4 Rofecoxib Industry Restraints
3 Rofecoxib Market by Manufacturers
  1. 3.1 Global Rofecoxib Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Rofecoxib Sales by Manufacturers (2021-2026)
  3. 3.3 Global Rofecoxib Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Rofecoxib Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Rofecoxib Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Rofecoxib Manufacturers, Product Type & Application
  7. 3.7 Global Rofecoxib Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Rofecoxib Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Rofecoxib Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Rofecoxib Tier 1, Tier 2, and Tier 3
4 Rofecoxib Market by Type
  1. 4.1 Rofecoxib Type Introduction
  2. 4.1.1 Oral Suspension.
  3. 4.1.2 Tablet-Form
  4. 4.2 Global Rofecoxib Sales by Type
  5. 4.2.1 Global Rofecoxib Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Rofecoxib Sales by Type (2021-2032)
  7. 4.2.3 Global Rofecoxib Sales Market Share by Type (2021-2032)
  8. 4.3 Global Rofecoxib Revenue by Type
  9. 4.3.1 Global Rofecoxib Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Rofecoxib Revenue by Type (2021-2032)
  11. 4.3.3 Global Rofecoxib Revenue Market Share by Type (2021-2032)
5 Rofecoxib Market by Application
  1. 5.1 Rofecoxib Application Introduction
  2. 5.1.1 Juvenile Rheumatoid Arthritis
  3. 5.1.2 Dysmenorrhea
  4. 5.1.3 Migraine
  5. 5.1.4 Rheumatoid Arthritis
  6. 5.1.5 Acute Pain Conditions
  7. 5.1.6 Osteoarthritis
  8. 5.2 Global Rofecoxib Sales by Application
  9. 5.2.1 Global Rofecoxib Sales by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Rofecoxib Sales by Application (2021-2032)
  11. 5.2.3 Global Rofecoxib Sales Market Share by Application (2021-2032)
  12. 5.3 Global Rofecoxib Revenue by Application
  13. 5.3.1 Global Rofecoxib Revenue by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Rofecoxib Revenue by Application (2021-2032)
  15. 5.3.3 Global Rofecoxib Revenue Market Share by Application (2021-2032)
6 Global Rofecoxib Sales by Region
  1. 6.1 Global Rofecoxib Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Rofecoxib Sales by Region (2021-2032)
  3. 6.2.1 Global Rofecoxib Sales by Region (2021-2026)
  4. 6.2.2 Global Rofecoxib Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Rofecoxib Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Rofecoxib Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Rofecoxib Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Rofecoxib Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Rofecoxib Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Rofecoxib Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Rofecoxib Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Rofecoxib Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Rofecoxib Revenue by Region
  1. 7.1 Global Rofecoxib Revenue by Region
  2. 7.1.1 Global Rofecoxib Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Rofecoxib Revenue by Region (2021-2026)
  4. 7.1.3 Global Rofecoxib Revenue by Region (2027-2032)
  5. 7.1.4 Global Rofecoxib Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Rofecoxib Revenue (2021-2032)
  8. 7.2.2 North America Rofecoxib Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Rofecoxib Revenue (2021-2032)
  11. 7.3.2 Europe Rofecoxib Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Rofecoxib Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Rofecoxib Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Rofecoxib Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Rofecoxib Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Wuhan Xinxin Jiali Biotechnology Co. LTD
  2. 8.1.1 Wuhan Xinxin Jiali Biotechnology Co. LTD Company Information
  3. 8.1.2 Wuhan Xinxin Jiali Biotechnology Co. LTD Business Overview
  4. 8.1.3 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product Portfolio
  6. 8.1.5 Wuhan Xinxin Jiali Biotechnology Co. LTD Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Rofecoxib Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck Rofecoxib Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Rofecoxib Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Rofecoxib Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
  20. 8.4.1 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Company Information
  21. 8.4.2 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Business Overview
  22. 8.4.3 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product Portfolio
  24. 8.4.5 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Developments
  25. 8.5 Chengdu Meinkai Chemical Co. LTD
  26. 8.5.1 Chengdu Meinkai Chemical Co. LTD Company Information
  27. 8.5.2 Chengdu Meinkai Chemical Co. LTD Business Overview
  28. 8.5.3 Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Chengdu Meinkai Chemical Co. LTD Rofecoxib Product Portfolio
  30. 8.5.5 Chengdu Meinkai Chemical Co. LTD Recent Developments
  31. 8.6 Tremeau
  32. 8.6.1 Tremeau Company Information
  33. 8.6.2 Tremeau Business Overview
  34. 8.6.3 Tremeau Rofecoxib Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Tremeau Rofecoxib Product Portfolio
  36. 8.6.5 Tremeau Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Rofecoxib Value Chain Analysis
  2. 9.1.1 Rofecoxib Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Rofecoxib Production Mode & Process
  6. 9.2 Rofecoxib Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Rofecoxib Distributors
  9. 9.2.3 Rofecoxib Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst